INCY insider trading — Incyte Corp
No open-market insider purchases or sales were filed for Incyte Corp (INCY) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent INCY insider transactions
Every Form 4 filed by Incyte Corp officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Heeson Lee | EVP, Head of Incyte Intl | F · Tax withholding | Direct | 463 | $117.14 | $54K | Form 4 |
| Sep 30, 2026 | Baker Bros. Advisors Lp, 667, L.P., Baker Bros. Advisors (Gp) Llc, Baker Brothers Life Sciences Lp, Baker Felix, Baker Julian | Director | A · Grant/award | Indirect | 644 | — | — | Form 4 |
| Sep 30, 2026 | Harrigan Edmund | Director | A · Grant/award | Direct | 206 | $121.35 | $25K | Form 4 |
| Sep 30, 2026 | Clancy Paul J | Director | A · Grant/award | Direct | 203 | $121.35 | $25K | Form 4 |
| Sep 22, 2026 | Gardner David H | EVP, Chief Strategy Officer | F · Tax withholding | Direct | 920 | $126.93 | $117K | Form 4 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | M · Option exercise · 10b5-1 | Direct | 23,218 | $66.39 | $1.54M | Form 4 |
| Sep 15, 2026 | Cagnoni Pablo J | President, Global Head of R&D | S · Sale · 10b5-1 | Direct | 23,218 | $120.49 | $2.80M | Form 4 |
| Aug 25, 2026 | Basi Ramitpal K | EVP, Human Resources | F · Tax withholding | Direct | 504 | $129.72 | $65K | Form 4 |
| Aug 19, 2026 | Cagnoni Pablo J | President, Global Head of R&D | S · Sale · 10b5-1 | Direct | 10,801 | $125.56 | $1.36M | Form 4 |
| Aug 12, 2026 | Cagnoni Pablo J | President, Global Head of R&D | S · Sale · 10b5-1 | Direct | 10,803 | $120.04 | $1.30M | Form 4 |
| Aug 5, 2026 | Cagnoni Pablo J | President, Global Head of R&D | S · Sale · 10b5-1 | Direct | 10,640 | $122.69 | $1.31M | Form 4 |
| Aug 5, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 2,207 | $106.47 | $235K | Form 4 |
| Aug 5, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 2,207 | $123.99 | $274K | Form 4 |
| Aug 3, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 6,055 | $105.43 | $638K | Form 4 |
| Aug 3, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 6,055 | $120.43 | $729K | Form 4 |
| Jul 31, 2026 | Cagnoni Pablo J | President, Global Head of R&D | S · Sale · 10b5-1 | Direct | 15,888 | $119.70 | $1.90M | Form 4 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | M · Option exercise · 10b5-1 | Direct | 39,712 | $74.37 | $2.95M | Form 4 |
| Jul 31, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | S · Sale · 10b5-1 | Direct | 41,899 | $119.46 | $5.01M | Form 4 |
| Jul 16, 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | S · Sale · 10b5-1 | Direct | 1,877 | $114.73 | $215K | Form 4 |
| Jul 16, 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | A · Grant/award · 10b5-1 | Direct | 9,798 | — | — | Form 4 |
| Jul 16, 2026 | Tray Thomas | Principal Accounting Officer | A · Grant/award | Direct | 2,834 | — | — | Form 4 |
| Jul 16, 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | A · Grant/award | Direct | 5,916 | — | — | Form 4 |
| Jul 16, 2026 | Cagnoni Pablo J | President, Global Head of R&D | A · Grant/award | Direct | 13,403 | — | — | Form 4 |
| Jul 16, 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S · Sale · 10b5-1 | Direct | 1,093 | $115.01 | $126K | Form 4 |
| Jul 16, 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A · Grant/award · 10b5-1 | Direct | 7,857 | — | — | Form 4 |
| Jul 16, 2026 | Basi Ramitpal K | EVP, Human Resources | A · Grant/award | Direct | 4,991 | — | — | Form 4 |
| Jul 16, 2026 | Hoffman Richard A. | EVP & General Counsel | A · Grant/award | Direct | 7,395 | — | — | Form 4 |
| Jul 16, 2026 | Gardner David H | EVP, Chief Strategy Officer | A · Grant/award | Direct | 7,395 | — | — | Form 4 |
| Jul 16, 2026 | Meury William | Chief Executive Officer | A · Grant/award | Direct | 26,807 | — | — | Form 4 |
INCY insider trading FAQ
Are insiders buying INCY stock?
Not on the open market. In the last 90 days, Incyte Corp insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading INCY?
No insider bought or sold on the open market in the last 90 days.
Where does INCY insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.